Drug application
NORPACE CR (DISOPYRAMIDE PHOSPHATE)
Drugs@FDA NDA 018655 · PFIZER
Key facts
| Drug name | NORPACE CR |
|---|---|
| Active ingredients | DISOPYRAMIDE PHOSPHATE |
| Application type | NDA |
| Application number | 018655 |
| Company | PFIZER |
| Dosage forms | CAPSULE, EXTENDED RELEASE, ORAL |
| Strength | EQ 100MG BASE |
| Marketing status | Prescription |
| Reference listed drug | Yes |
| Latest submission class | Type 3 - New Dosage Form |
| Latest submission status date | Jul 20, 1982 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.